TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases TrimTech Therapeutics, a biotech company that uses targeted protein breakdown (TPD) for the treatment of neurodegenerative diseases, has today announced…
Philanthropic investment establishes research center to advance precision diagnosis for diseases An outstanding philanthropic investment of $21 million will establish a groundbreaking research center to advance the precision diagnosis of diseases…
